[Thymalin in the treatment of herpetic stomatitis in children].
Kazantseva. I A IA; Bikbulatov. R M RM
Key Findings
- Thymalin did not speed up acute symptom resolution
- Thymalin helped achieve a stable anti‑relapse effect in high‑risk children
- Immunological markers (CD4+, CD8+, antibodies) were monitored during treatment
Practical Outcomes
- For DIY health enthusiasts, thymalin might be considered only if you’re specifically trying to reduce recurrent herpetic mouth lesions, not for general performance or longevity. The evidence is limited and the benefit is modest, so it’s not a high‑priority supplement.
Summary
Thymalin, a peptide taken from cow thymus, was given to 44 kids with cold‑sore‑type mouth sores. It didn’t make the sores go away faster, but it seemed to lower the chance of the sores coming back later.
Abstract
Thymalin, a polypeptide drug obtained by extraction from cattle thymus, was used in therapy of 44 children with acute and relapsing herpetic stomatitis. Laboratory studies included direct analysis of fluorescent antibodies in buccal mucosa epithelium to verify the clinical diagnosis and enzyme immunoassay of specific antigen in salivary samples before and after therapy. Enzyme immunoassay was also used to assay antibodies to herpes simplex virus in the blood serum over the course of treatment. Immunity status over the course of treatment was assessed by indirect immunofluorescence with monoclonal antibodies used to study lymphocyte subpopulations CD4+ inductor-helpers, CD8+ natural killers, and CD4+/CD8+ ratio. Thumalin therapy was not conducive to a rapid abatement of acute symptoms in stomatitis; but such therapy is justified, for in helps attain a stable antirelapse effect in children at a high risk of developing stomatitis recurrences.
Study Information
pubmed
1994